Taipei, Wednesday, April 16, 2014 12:44 (GMT+8)
partly cloudy
Taipei
28°C
Taiwan PCB makers ramping up capacity - related company info
Ingrid Lee, Taipei; Steve Shen, DIGITIMES [Monday 19 November 2012]
  • APEX Medical
  • Performance
    The company's stock price closed at NT$34.95 on the TSE on Tuesday, April 15, 2014.
    The company has reported consolidated revenues of NT$220 million for March 2014, representing a 35.5% increase on month and 13.1% increase on year.
    For the third quarter of 2013, the company totaled NT$494 million in consolidated revenues, down 3.1% sequentially and up 1.6% on year.
    Brief

    Full name: APEX Medical

    Chinese name: 雃博股份有限公司

    Short name: Apex

    Stock code: 4106

    Tax ID: 23632773

    Market: TSE

    Established: 17 Mar 1990

    Paid in capital: NT$833.86 million

    Listed on TSE: 8 Nov 2004

    Listed on OTC: 22 Jan 2002

    Listed on ESB: 2 Jan 2002

    Public since: 19 Jul 1999

    Website: cht.apexmedical.com.tw

  • Latest stock
    Apex [4106] historical stock price (NT$)
    DateVolume (k)TransactionsValueOpenHighLowCloseChangeAskBid
    16-Apr 72   35.10 35.10 34.60 34.75-0.20-0.57%  
    15-Apr 169 99 5,870,435 34.80 34.95 34.50 34.95+0.35+1.01% 34.95 34.85
    14-Apr 302 151 10,509,700 35.10 35.20 34.30 34.60-0.40-1.14% 34.75 34.60
    11-Apr 394 237 13,774,879 35.00 35.30 34.40 35.00+0.00+0.00% 35.05 35.00
    10-Apr 428 187 14,965,075 35.30 35.40 34.70 35.00-0.30-0.85% 35.00 34.80
    9-Apr 278 171 9,804,583 35.40 35.40 35.15 35.30+0.00+0.00% 35.30 35.20
    8-Apr 531 304 18,696,397 34.80 35.70 34.70 35.30+0.40+1.15% 35.35 35.30
    7-Apr 219 130 7,661,918 35.10 35.25 34.80 34.90-0.45-1.27% 34.95 34.90
    • Source: TSE, compiled by Digitimes
    Latest sales

    Apex: Consolidated revenues, Mar 2013 - Mar 2014 (NT$m)

    Month

    Sales

    M/M

    Y/Y

    YTD

    Y/Y

    Mar-14

    220

    35.5%

    13.1%

    585

    19.1%

    Feb-14

    162

    (12.7%)

    18.5%

    358

    20.4%

    Jan-14

    186

    7%

    16%

    186

    16%

    Dec-13

    174

    21.5%

    6.5%

    2,013

    9.1%

    Nov-13

    143

    (18.2%)

    (0.1%)

    1,809

    7.5%

    Oct-13

    175

    15.7%

    19.3%

    1,669

    8.4%

    Sep-13

    151

    (4.3%)

    (11.1%)

    1,435

    3%

    Aug-13

    158

    (7%)

    (1%)

    1,334

    9.1%

    Jul-13

    170

    16.7%

    8.3%

    1,170

    10.1%

    Jun-13

    146

    (22.5%)

    4.3%

    989

    8.7%

    May-13

    188

    14.6%

    11.4%

    844

    9.5%

    Apr-13

    164

    (15.7%)

    2.5%

    656

    8.9%

    Mar-13

    194

    42%

    9.1%

    492

    11.2%

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, April 2014

    Apex: Consolidated revenues, 3Q12 - 3Q13 (NT$m)

    Quarter

    Sales

    Q/Q

    Y/Y

    YTD

    Y/Y

    3Q-13

    494

    (3.1%)

    1.6%

    1,496

    7.4%

    2Q-13

    510

    3.9%

    10%

    1,002

    10.5%

    1Q-13

    491

    8.5%

    11.1%

    491

    11.1%

    4Q-12

    453

    (6.9%)

    (2.1%)

    1,846

    5.6%

    3Q-12

    487

    4.9%

    18.6%

    1,393

    8.3%

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, April 2014

    Latest balance sheet and income statement

    Apex: Consolidated balance sheet, 4Q12 - 4Q13 (NT$k)

    Item

    4Q-2013

    3Q-2013

    2Q-2013

    1Q-2013

    4Q-2012

    Current assets

    1,078,245

    1,029,489

    1,095,523

    1,033,265

    972,102

    Intangible assets

    577,954

    572,223

    564,063

    568,064

    588,958

    Non-current assets

    1,351,082

    1,334,102

    1,328,174

    1,335,182

    1,358,687

    Assets

    2,429,327

    2,363,591

    2,423,697

    2,368,447

    2,330,789

    Current liabilities

    599,379

    606,240

    619,159

    575,018

    573,496

    Non-current liabilities

    143

    5,702

    5,887

    6,082

    6,892

    Liabilities

    599,522

    611,942

    625,046

    581,100

    580,388

    Stockholders' equity

    1,829,805

    1,751,649

    1,798,651

    1,787,347

    1,750,401

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, April 2014

    Apex: Consolidated income statement, 3Q12 - 3Q13 (NT$k)

    Item

    3Q-2013

    2Q-2013

    1Q-2013

    4Q-2012

    3Q-2012

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    Gross sales

    494,330

     

    0

     

     

     

    402,579

     

    485,724

     

    Operating revenue

    494,330

    100%

    510,292

     

    491,346

    122%

    452,975

    112.5%

    486,578

    100.2%

    Gross profit (loss) from operations

    198,806

    40.2%

    228,538

     

    192,128

    47.7%

    194,187

    48.2%

    199,882

    41.2%

    Operating expenses

    175,425

    35.5%

    164,532

     

    140,133

    34.8%

    152,137

    37.8%

    143,069

    29.5%

    Operating income (loss)

    23,381

    4.7%

    64,006

     

    51,995

    12.9%

    42,050

    10.4%

    56,813

    11.7%

    Non-operating revenues and gains

     

     

     

     

    4,091

    1%

    10,983

    2.7%

    7,952

    1.6%

    Non-operating expenses and losses

    3,038

    0.6%

    0

     

     

     

     

     

    7,104

    1.5%

    Income from continuing operations before income tax

    26,419

    5.3%

    68,708

     

    56,086

    13.9%

    51,980

    12.9%

    64,525

    13.3%

    Net income (loss)

    15,086

    3.1%

    40,460

     

    44,398

    11%

    34,925

    8.7%

    51,084

    10.5%

    Fully-diluted earnings per share (NT$)

    0.2

     

    0.4

     

    0.5

     

    0.3

     

    0.6

     

    Simple earnings per share (NT$)

     

     

     

     

     

     

     

     

    0.5

     

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, April 2014

  • APEX Medical full profile
Realtime news
  • Mitac Information Technology becomes Asia Pacific partner for Google Cloud Platform

    Before Going to Press | Apr 15, 21:16

  • Lumax looks to improving sales and profits in 2014

    Before Going to Press | Apr 15, 21:15

  • Commentary: Korea-based panel makers bump up competition in the Ultra HD TV panel segment

    Before Going to Press | Apr 15, 20:55

  • TSMC, UMC look to sequential revenue gains in 2Q14

    Before Going to Press | Apr 15, 20:35

  • SAS to introduce new shareholders, raise additional capital

    Before Going to Press | Apr 15, 20:02

  • Taiwan market: Consumers upset by better Asustek ZenFones available in China

    Before Going to Press | Apr 15, 19:17

  • EU to impose anti-dumping tariffs on China-made PV-use glass

    Before Going to Press | Apr 15, 19:12

  • Taiwan motherboard makers expected to see growth in 2Q14 shipments

    Before Going to Press | Apr 15, 19:11

Pause
 | 
View more

16-Apr-2014 11:46 (GMT+8)

 LastChange

TAIEX (TSE)8916.31-0.40-0% 

TSE electronic339.87-0.03-0.01% 

GTSM (OTC)144.03+0.43+0.3% 

OTC electronic179.29+0.25+0.14% 

2014 China smartphone market and industry
China FPD industry, 2013-2016
2014 global smartphone market forecast
  • China flat panel display industry outlook, 2013-2016

    This Digitimes Research Special Report outlines and analyzes the key trends and players that are influencing the continued development of China large-size and small-to medium size TFT LCD panel industry, while providing related growth forecasts for the industry through 2016.

  • TD-LTE market developments and forecast, 2014-2016

    TD-LTE has become the mainstream global choice for the construction of 4G asymmetric frequency spectrum networks. This Digitimes Research Special Report examines the current global status of TD-LTE, and forecasts developments in the TD-LTE supply chain in China and worldwide through 2016.